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The paradox of non-evidence based, publicly funded complementary alternative medicine 
in the English National Health Service:  an explanation 
Abstract 
Despite the unproven effectiveness of many practices that are under the umbrella term 
‘complementary alternative medicine’ (CAM), there is provision of CAM within the English 
National Health Service (NHS). Moreover, although the National Institute for Health and 
Care Excellence was established to promote scientifically validated medicine in the NHS, the 
paradox of publicly funded, non-evidence based CAM can be explained as linked with 
government policy of patient choice and specifically patient treatment choice. Patient 
choice is useful in the political and policy discourse as it is open to different interpretations 
and can be justified by policy-makers who rely on the traditional NHS values of equity and 
universality. Treatment choice finds expression in the policy of personalised healthcare 
linked with patient responsibilisation which finds resonance in the emphasis CAM places on 
self-care and self-management. More importantly, however, policy-makers also use patient 
choice and treatment choice as a policy initiative with the objective of encouraging 
destabilisation of the entrenched healthcare institutions and practices considered resistant 
to change. This political strategy of system reform has the unintended, paradoxical 
consequence of allowing for the emergence of non-evidence based, publicly funded CAM in 
the NHS. The political and policy discourse of patient choice thus trumps evidence based 
medicine, with patients that demand access to CAM becoming the unwitting beneficiaries. 
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Using the National Health Service (NHS) in England and Wales as the example this paper 
suggests that the provision of non-evidence based complementary alternative medicine 
(CAM) in a public healthcare system appears to be a paradox. In a healthcare system funded 
by general taxation the general public ought to be able to expect that their money is used to 
promote scientifically validated medicine rather than treatments of little clinically proven 
benefit.  In the United Kingdom, the National Institute for Health and Care Excellence or 
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NICE [1], an independent organisation, was set up by the Government in 1999 to achieve 
this objective, namely to promote scientifically validated medicine and to decide which 
drugs and treatments are to be available in the NHS in England and Wales.  Despite this 
emphasis on evidence-based medicine a space for CAM in the NHS has been constructed.  
The paper argues that it is the emphasis of governmental policy discourse on patient choice 
and patient treatment choice which has lead to non-evidence based CAM being made 
available in a public healthcare system.  
Complementary alternative medicine (CAM) is a term that describes a vast number of 
treatment modalities. In 2000, the House of Lords Committee on Science and Technology 
defined CAM as a ‘diverse group of health-related therapies and disciplines which are not 
considered to be a part of mainstream medical care’. [2] While this definition immediately 
differentiates CAM from orthodox medicine, it does not exclude the practice of CAM by the 
medical profession in the UK and nor does it exclude the referral of patients by orthodox 
medical practitioners to CAM practitioners. The principal CAM disciplines include those 
which claim to have an individual diagnostic approach, namely osteopathy and chiropractic, 
acupuncture, herbal medicine and homeopathy. These treatments are the ones used most 
widely by the public [3], and are also the most likely to have been made available by the 
NHS. [4]   
As the Committee report suggests, similar to CAM modalities generally, these five 
treatments have very different theories for their modes of action [5], and none of these 
theories are congruent with current scientific knowledge. They have scientifically 
established efficacy only in a limited number of ailments [2; 5] but have the greatest claim 
to professional organisation by their practitioners. [6] In the UK, practitioners of osteopathy 
and chiropractic are regulated in their professional activities and education by Acts of 
Parliament. [7; 8] There are also professional organisations for medical practitioners who 
practise osteopathy, acupuncture or homeopathy. [9]  
Only a few of the CAM modalities have been evaluated by NICE when it has developed 
clinical guidance. [10] Most CAM therapies have not been subjected to randomised 
controlled trials (RCTs), the gold standard in the hierarchy of experimental scientific 
evidence. For many of them, there is not even research evidence which is lower in the 
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hierarchy of evidence than RCTs, such as non-randomised studies or descriptive studies. [5] 
Nevertheless, despite the unproven effectiveness of many CAM practices, there is demand 
by patients for and provision of non-evidence-based, publicly funded CAM. [3] This demand 
may be due, amongst other things, to the dissatisfaction with biomedicine because of the 
side-effects of drugs and their lack of effectiveness in many chronic conditions; the belief 
that CAM is less invasive and more natural; the greater involvement by the patient in the 
treatment; and the different relationship between CAM practitioner and client. [11] 
Although the figures are not up-to-date, it has been estimated that about 10% of the overall 
contacts with CAM practitioners in England are publicly funded as part of the NHS. [12] 
Access to CAM in the NHS can be through the referrals of General Practitioners (GPs) and, in 
NHS hospitals, by NHS-employed healthcare professionals as part of an integrated approach 
to cancer care and as part of end of life care. [6] Publicly funded homeopathy is still being 
made available in the three homeopathic hospitals in England, including the Royal London 
Hospital for Integrated Medicine. [13] To set the scene, the paper sketches a brief historical 
overview of the role of CAM in the NHS before discussing the implications of the recent 
health policies focused on patient choice.  
A historical overview of CAM in the NHS 
The National Health Service Act 1946 did not prohibit the provision of CAM under the NHS. 
Some groups of CAM practitioners had argued for inclusion in the NHS but entry was made 
subject to the reorganisation of CAM practitioners with recognised training schemes and 
also CAM practitioners working as medical auxiliaries under the direction of the medical 
profession. This proposal was rejected. [14] CAM could, however, still be provided by 
qualified medical practitioners as part of the NHS. Although the Medical Registration Bill 
1858 had been intended to prevent the practice of non-orthodox medicine by medical 
practitioners, an amendment to the Bill instigated by Dr Quin, an influential doctor and 
homeopath, enabled the Privy Council to withdraw the right to award degrees from any 
university trying to dictate the type of medicine practised by its medical graduates. [15] 
Thus, under the Medical Act 1858, conventionally trained doctors can legally practise other 
types of medicine. [13] However, with the exception of homeopathy provided by medical 
practitioners, NHS cover of CAM treatment was rare [16; 9; 15] because the medical 
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establishment, through its trade union body the British Medical Association (BMA), and its 
medical licensing body the General Medical Council (GMC), kept control over any deviation 
from the biomedical model by orthodox practitioners, thus restricting the adoption of CAM 
treatments. [11; 14] 
Interest in CAM experienced a considerable increase in the mid-1960s, possibly as part of an 
emerging medical counter-culture driven by the public interest in alternative lifestyles. This 
was associated with a rejection of scientific progress and professional experts within 
orthodox medicine. [17; 18] Growing demand for CAM by patients may also have been 
linked to the desire to try out alternative therapies, not only because of the perceived lack 
of efficacy and safety issues of orthodox treatments but as a challenge to professional 
experts. [18; 11] However, at that time, provision of CAM within the NHS was still largely 
restricted to the homeopathic hospitals because of the general opposition of the medical 
profession and the BMA to alternative medicine. [19; 18] The GMC was also opposed to the 
practice of unorthodox therapies. However, it relaxed its stance after 1983. [20; 16; 11]  
The development of patient choice and treatment choice in the NHS 
The Conservative government’s 1989 White Paper, Working for Patients, set in motion the 
market reforms in the NHS. It linked these reforms with the objective of increasing choice 
for the patient, specifically greater choice of services. [21] Although the choice originally 
given to patients was very limited, namely to have a choice between GPs [22], choice has 
become an instrumental aim of policy makers. When New Labour first came to power in 
1997, the emphasis was on the value of equity rather than featuring choice at first [23; 24]. 
New Labour won three consecutive elections by moving away from the socialist principles of 
Old Labour with the aim of providing a synthesis between capitalism and socialism and 
emphasising the use of free markets to deliver economic efficiency and social justice. With 
the introduction of the NHS Plan in 2000, patient choice was acknowledged as an important 
theme for New Labour. [25; 22] In 2010, choice was again confirmed as a principle in Equity 
and Excellence: Liberating the NHS, the White Paper published by the new coalition 
government formed by the Conservatives and Liberal Democrats. [26] Under the coalition 
government, patients were to have the choice of any qualified provider and choice of GP 
practice, choice in care for long-term conditions and now also choice of treatment. Patient 
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choice is enshrined in the new edition of the NHS Constitution for England [27] and the 
Health and Social Care Act 2012 referring to the patient having a right to make choices and 
being involved in discussions about these healthcare choices. There is of course a difference 
between a policy of patient choice of GP or of the hospital and time of appointment and a 
patient choice of treatment, even more so patient choice of publicly funded CAM treatment. 
When healthcare is funded by the public a choice of treatments for which there is no 
evidence of effectiveness such as much of CAM seems a paradox. While NICE was set up by 
government to ensure that medicines and treatments are clinically proven, the 
government’s policy of treatment choice appears to suggest the public support through its 
taxes clinically unproven treatments. 
Treatment choice of CAM within the NHS 
With the introduction of the internal market and the emphasis on choice, CAM started to 
become more widely available via the NHS. [9] Increasing consumer demand in the private 
sector had exerted an impact on orthodox medical practitioners, in particular GPs, with a 
greater number of GPs practising one or more alternative therapies themselves. [16; 17; 18] 
The introduction of the new contracts enabled GPs that employed complementary 
therapists to be reimbursed by health authorities. [9] At the same time, GPs with 
fundholding practices could use their funds to purchase complementary therapies, for 
example, from CAM practitioners working outside the practice. [13] GPs could also refer 
patients for CAM to osteopaths and chiropractors as these practitioners had become state-
regulated. [7; 8]  
With New Labour, the growth of CAM within the NHS became subjected to a more 
systematic and collective decision-making process. [28] The choice policy was now focusing 
on equity and reductions in health variation rather than the market with its competition. For 
this purpose, New Labour established NICE to encourage uniform standards of treatment 
and promote evidence-based medicine across the NHS. [1] Thus, CAM therapies which were 
to be available on the NHS had to be scientifically validated. [29; 30] Although overall more 
CAM services were being accessed through the NHS, these were mostly paid for by patients 
directly. [4] A survey carried out in 2001 established that 50% of GP practices offered their 
patients some access to CAM treatments with the percentage of patients financially 
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supporting these services themselves having doubled. [4] It is not surprising, therefore, that 
in its response to the Report by the House of Lords Science and Technology Committee on 
CAM [2], the New Labour government emphasised that it supported the evaluation of CAM 
therapies by NICE but that only once a therapy had gained a critical mass of evidence 
supporting its efficacy should the NHS and the medical profession ensure that the public had 
access to it. [29]  
The current coalition government has taken a different approach. It supports patient choice 
of CAM as a policy goal rather than depending on the principles of evidence-based 
medicine. [31] Funding decisions on CAM are to be left to local decision-makers, the Clinical 
Commissioning Groups (CCGs), and the role of NICE has been reduced. It is therefore 
expected that, with the demand for CAM by patients at present not being satisfied by public 
funding, NHS expenditure on CAM will increase. Although the current NHS website, NHS 
Choices, states that there is no evidence of the effectiveness of, for example, homeopathy, 
it also provides information as to where patients can receive publicly funded homeopathy. 
[32] In addition, personal health budgets, which were introduced in November 2012, 
provide patients affected by chronic conditions with greater choice of treatment. [33; 34] 
These enable them to purchase publicly funded health-related services either directly or 
through a third party. [34; 35] Patients have used the mechanism of these personal budgets 
to fund non-evidence based CAM treatments such as aromatherapy. [33; 34]  
The usefulness of choice in political and policy discourse 
Current political and policy discourse demonstrates enthusiasm for patient choice and 
treatment choice in the NHS. This is despite the fact that choice has been attacked for what 
it represents. Choice is regarded by some as a ‘proxy for competition, marketisation and 
privatisation policies’, and is challenged because it is seen to be in conflict with the 
traditional values of the NHS, particularly the value of equity or fairness and social justice. 
[36; 37] Thus, as has been claimed: ‘The NHS is being dismantled and privatised … The 
disaster that is unfolding is overwhelming in its complexity and magnitude … [The NHS] has 
been made into a laboratory for market-based policy prescriptions.’ [38] Whether choice in 
the NHS is inextricably linked with market economies is, however, questionable. Taking 
patient choice of primary care providers as an example, there can only be meaningful choice 
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if there is competition amongst providers for patients.  Patients who are dissatisfied with 
the service of their GP would need to have the opportunity to switch practices. THE NHS 
healthcare market has of course never been a real but rather a quasi-market, and in many 
areas the choice of GPs is limited, with practices refusing patients if there are no spaces for 
new patients or the patients are from outside their catchment area. [39] Evidence also 
suggests that although choice of GP has been a policy objective since the healthcare reforms 
in 1990 it was rarely enacted by patients switching practices as patients’ main concern is 
generally being treated close to home. [22] 
Patient choice or individualist demand is also attacked as being in tension with healthcare 
which aims to be egalitarian. [40] In this light choice is criticised as the emphasis ought to be 
on the fair treatment of every patient, subject to the available resources, and in a 
healthcare system with limited resources, the range of options available has to be curtailed 
in order to achieve equality of provision of the core services. [41; 42] However, the 
conceptual foundations on which the English NHS is based conceal a number of tensions. 
The ambiguity of the original settlement values of comprehensiveness, universality, equity 
and ‘free at the point of delivery’ not only allows a large degree of policy divergence but has 
also enabled policy-makers of different political persuasions to use them to explain and 
justify their policies. [43; 40] The definition of equity or social justice can, for example, be 
stretched to encompass geographical equity of access, equity of access according to need 
and equity in terms of patients’ unequal capabilities and health literacy. Because of this 
inherent vagueness the policy of patient choice is able to co-exist with equity. [44; 45]  
Equity of access according to need is, for example, open to different interpretations and 
depends on whether need is defined according to a person’s negative health status or in 
terms of a person’s capacity to benefit. [44; 40] In a resource constrained system greater 
choice will be at the expense of some users judged less needy, whether they are considered 
to be less in need of acute assistance or less likely to benefit from treatment.  But needs-
assessment is controversial and may not be a purely medical assessment but also include 
social and moral judgments. [44; 46]  A lack of consensus regarding the interpretation of 
need makes it difficult to realise a fair healthcare system while at the same time unwittingly 
assisting the proponents of choice.  
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Similarly, inequitable access to NHS healthcare may also refer to patients having unequal 
capabilities and differential knowledge with which to make choices. [45]  Patients in higher 
socio-economic groups have, for example, been shown to be more able to act upon 
information often presented in an unfamiliar language by healthcare professionals.  They 
have greater self-confidence in the consultation room and are more aware of their 
entitlements, and where and when to access services. [45] This inequity has, for example, 
been countered by New Labour by extending patient choice to the less well-off, providing 
them with information about choices and helping them to communicate with healthcare 
professionals. [41; 45]   
Policy-makers of different political persuasion have thus been able to rely on the 
ambiguities of the definition of equity of access to help justify their policies.  The need for 
policy-makers to do so is no doubt due to the importance placed by the public on the 
founding principles of the NHS, so that any explicit movement away could cause significant 
political damage. [43]  In a similar vein, policy-makers have used and defended their patient 
choice policies as adhering to the settlement values of the NHS.  Patient choice is a useful 
tool as it enables policy-makers to give the impression to the electorate that they are 
responsive and pay attention to satisfying patient needs and patient demands. In recent 
years, governments have associated patient choice with the notion of personalised 
healthcare [47] and with the concept of personal health budgets [48] with their greater 
openness to CAM. At the same time, they have defended the individualist approach of 
personalised healthcare by linking these themes with the idea of making patients 
responsible for their own health and lifestyle choices, the notion of ‘patient 
responsibilisation’. [47; 48] 
CAM and the policy of personalised healthcare  
The concept of personalised healthcare introduced under New Labour is healthcare which is 
more tailored to the patient. Rather than people being given services when they needed 
them, it suggests that services can be influenced and shaped. [47] Personalised healthcare is 
a concept also promoted by the current coalition government, and this is seen as 
recognising that there are other issues in addition to medical needs that can impact on a 
person’s total health and wellbeing. [49]  
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The attempt to offer greater responsiveness in healthcare and greater choice and 
personalised healthcare to patients has found its expression in the emerging mechanism of 
the personal health budgets.  Experience with direct payments and personal budgets had 
already been gained in the social care sector. [34] The principle underlying the personal 
health budgets is that patients are to be allocated a budget, instead of directly provided 
services, with which they can purchase their own care and services. [48] The package of 
services so bought by the patient would be in addition to the comprehensive primary 
medical services provided by GPs. [48] These budgets were intended for patients with fairly 
stable and predictable conditions, such as patients with long-term chronic conditions. After 
a three year pilot programme started under New Labour, the scheme is now operational for 
people receiving NHS continuing care and plays a part in patient choice and personalised 
care planning, giving people more control over the money that is spent on their care. [50; 
51] In the social care sector, it was found that people receiving direct payments also used 
them to buy healthcare services which included CAM. [34] People with long term conditions 
claiming personal budgets for NHS healthcare and wishing to buy these treatment 
modalities will then be able to do so [34] because non-evidence based CAM treatments are 
not off-limit or discouraged. 
CAM and patient responsibility 
Personalised healthcare has been justified by both the New Labour and the coalition 
government in terms of the original NHS settlement. In this regard, New Labour expressly 
underlined the need to uphold the key principles of the NHS, specifically ‘equality and 
tackling inequalities’. [48] While the coalition government would not separate choice and 
personalisation of healthcare from the issue of cost management in the NHS, it also linked 
them with the value of equity [49; 50], thus making their fiscal policies more acceptable to 
the electorate. [52] Because the issue of cost management in the NHS is at the forefront of 
the political debate, policy-makers connected choice and personalised healthcare with the 
idea of patient ‘responsibilisation’. [52; 53] Individuals are expected to become more 
involved with their healthcare by taking more control of their lifestyle choices in relation to 
health. The emphasis on the individual to assume responsibility for the management of her 
own health and healthcare and making responsible choices is also encapsulated in the NHS 
Constitution. [27] The theme of ‘responsibilisation’ is continued with the personal health 
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budgets. Thus, policy-makers of all political persuasions have related personal health 
budgets to people having independence and choice but also responsibility. [48; 52] Making 
patients take responsibility for their health and so reducing the acute episodes and hospital 
admissions of patients with long-term chronic conditions, rather than being resource 
intensive might lead to resource savings. Affording the patients choice and simultaneously 
making them responsible for their healthcare, it has been argued, will deepen their 
commitment to the value of solidarity [52] and lessen dependence on the NHS with the 
potential benefit of reducing the costs of publicly funded healthcare. [50; 52; 53]  
‘Responsibilisation’ by making patients take more control over their health is a concept that 
also underlies the healthcare model of CAM. [16; 54] Unlike the biomedical model, the 
adoption of CAM with its emphasis on self-management and self-care will support a 
government strategy of ‘responsibilisation’, particularly of patients with chronic illnesses 
where CAM treatments have their place. Viewed in this light, personal health budgets 
affording patients this choice would achieve their intended purpose: patients’ reliance on 
CAM might lead to growing self-reliance in health matters and even help curtail the rising 
costs of healthcare in the field of chronic care. According to the report on the early 
experiences of personal health budget holders, patients planned on using their budgets on 
chiropractic, osteopathy, Reiki, massage, reflexology, aromatherapy and hydrotherapy 
amongst other things. [55] 
For policy-makers, the ability to defend their patient treatment choice policies as being 
consistent with the original settlement values helps to deflect the criticisms of the 
opponents of choice who view these policies as a strategy of marketisation. [52] However, 
choice does not only play this role. The use of patient choice by policy-makers as a device 
has additional functions that conceal different political intentions. [52; 36; 56] 
Choice as a mechanism of destabilisation 
The choice policy may be seen as a response to broader social change but it can also be 
interpreted as a tool to encourage change, as a policy intended to disrupt or destabilise the 
entrenched institutional architecture of the NHS and encourage reform. [36; 52; 57]  Policy 
documents depict this dichotomy pointing to personalisation and choice as a result of 
cultural change, as user-driven. [48; 51; 52]  At the same time they suggest that patient 
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choice will bring about a cultural shift, is disruptive and encourages further destabilisation. 
[48; 52]  
Thus, in the context of the NHS, the motivation for the patient choice policy is complex, is 
not simply user-led and not limited to its function of increasing consumer satisfaction for 
electoral reasons. [57] Rather, apparent from policy documents, the policy of patient choice 
is a deliberate mechanism of destabilisation in order to achieve quality improvement, 
greater efficiency and responsiveness, administrative modernisation and cost containment 
in the NHS. [57]  In this light, policy makers of different political parties refer to choice and 
personalisation as ‘proxies for instability’ [36] to achieve system reform, and ‘as a radical 
agenda which will shake up the health service’. [526]  
To take personal health budgets as an example, they can be seen as having a disruptive 
effect because of the way in which they are expected to cause change in NHS funding. [52; 
48] As cash payments to the patient, they constitute a radical move from the tradition of 
risk-pooling in the NHS, difficult to square with the principles of the NHS where services are 
meant to be free at the point of delivery [52; 48] They can be regarded as a as a major 
system-level reform as they are likely to affect the use of a wide range of services and 
support in the NHS.  [57; 48] As such they are likely to encourage the search for alternatives 
to traditional NHS provision, supporting innovative services outside the scope of traditional 
NHS purchasing and creating a dynamic provider market allowing popular services such as 
CAM to grow and adapt. [48] 
 
In addition, the Health and Social Care Act 2012 has led to extensive restructuring of the 
English NHS, particularly in the primary care sector. It has extended primary care provision 
to include ‘any qualified provider’. [59] The intention is to encourage ‘fair and effective 
competition … [as] a means to give greater choice and control to patients to access high 
quality care’. [60] The commissioning of services which were outside the scope of NHS 
provision has brought about a reorganisation of the primary care sector and has changed 
practices within the NHS.  At the same time the policy of patient choice may be a useful tool 
to encourage wider-ranging institutional change in the NHS. Patients demanding increased 
access to non-evidence based CAM in the NHS have become the unwitting beneficiaries of 
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this strategy of destabilisation as the volatility in the primary care sector has opened up a 
greater space for CAM within the NHS. [58]  
Conclusion 
Although the availability of non-evidence based, publicly funded CAM in the NHS is a 
paradox, it can be explained by the policy of patient treatment choice advocated by policy-
makers of different political persuasions. This policy is not simply driven by the hope for 
electoral gains from promising citizens and patients that their demands and choices as users 
of public services will be satisfied. It is also not simply a theme in developing a market 
model of the NHS because policy-makers also wish to make their patient choice policy 
palatable to the public by relying on the traditional values of the NHS. The narrative of 
personalised healthcare and personal health budgets linked with the notion of 
‘responsibilisation’ is clearly evidence of this need for justification. These objectives of 
policy-makers are evidently significant but the choice policy has a greater role. It is used to 
bring about change within the NHS and as a mechanism to destabilise the institutional 
structure of the NHS in order to encourage change and reform. Personalised healthcare and 
personal health budgets can thus be regarded as ‘proxies for instability as a dynamic of 
system reform’. [36]  
CAM fits into this overall picture and the lack of evidence for much of CAM is of little 
relevance. The policy of the current coalition government of extending primary care 
provision to include ‘any qualified provider’ includes CAM providers. Commissioning 
services within the NHS such as CAM which are currently outside the scope of NHS provision 
and commissioning services from providers not previously employed by the NHS is leading 
to volatility and destabilisation in the primary care sector. The provision of such services is 
clearly driven by consumer demand but at the same time the policy of patient choice is 
useful as a strategy to encourage wider-ranging institutional re-organisation in the NHS. 
CAM with its emphasis on self-management and self-care certainly fits neatly into the idea 
of making patients take responsibility for their health and lifestyle choices. Because of the 
potentially lower cost of CAM and the possibly reduced need for medical personnel [11] 
dependency of patients on the NHS might be lessened.  Public funding of CAM could 
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therefore even be seen as supporting the founding values of equity and solidarity and aiding 
the drive for fiscal austerity.  
In the political and policy discourse, despite the existence of NICE policy-makers’ patient 
choice appears to trump evidence based healthcare and encourages the availability of CAM 
in the NHS despite the unproven effectiveness and potential lack of safety of most CAM 
treatment modalities. In this context, homeopathy is a particularly relevant example. In 
2009, the House of Commons Science and Technology Committee had as its task to 
determine whether scientific evidence supports government policies that allow the funding 
and provision of homeopathy through the NHS. The Committee concluded that there was 
no evidence that homeopathy is anything more than a placebo. It recommended that the 
government should stop allowing the funding of homeopathy on the NHS. The funding of 
homeopathic hospitals—hospitals that specialise in the administration of placebos—should 
not continue, NHS doctors should not refer patients to homeopaths and homeopathy 
should be withdrawn from the NHS. [30] Even the government’s own Chief Scientific Adviser 
suggested that the government stop endorsing homeopathy on the NHS. However, the 
response by the current coalition government to the Committee was that decisions on the 
appropriateness and availability of homeopathy were to be made by doctors, local 
healthcare commissioning groups and patients. As the government stressed: ‘Efficacy 
cannot be the most important factor when selecting treatment; the overriding reason for 
the NHS provision of homeopathy was that homeopathy provides patient choice.’ [31] 
Ministerial support for homeopathy is apparent to this day. [61]  
Whatever the benefits to policy-makers of patient treatment choice as an electoral ploy or a 
mechanism to bring about change in the NHS, the question remains whether the NHS, while 
upholding the principles of evidence based medicine, should provide non-evidence based 
CAM.   If NICE was set up as an institution to advise on cost-effective and clinically proven 
treatments then these criteria should also apply to publicly funded CAM.  Otherwise one 
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